Gene: leucine-rich repeat kinase 2; LRRK2


Gene Symbol: LRRK2
OMIM: 609007
Chromosome location: 12q12

Related informations:  NCBI Gene  Genome Browser  Ensembl  UniProt  GeneCards  Kyoto Encyclopedia  BioGPS  HGNC  

Parkinson disease 8 || c.6055G>A

Phenotype:    Parkinson disease 8
Dna Change:    c.6055G>A
Protein Change:    p.Gly2019Ser
Mutation Type:    Substitution
Mutation Effect:    Missense
Location:    exon 41
Transcript:    NM_198578.3

PopulationEthnic GroupRegionMutation FrquencyCoalescence TimeReference
FranceNANA5 patientsNALesage S et al., 2007Lesage S, Janin S, Lohmann E, Leutenegger AL, Leclere L, Viallet F, Pollak P, Durif F, Thobois S, Layet V, Vidailhet M, Agid Y, Dürr A, Brice A, , Bonnet AM, Borg M, Broussolle E, Damier P, Destée A, Martinez M, Penet C, Rasco O, Tison F, Tranchan C, Vérin M, . LRRK2 exon 41 mutations in sporadic Parkinson disease in Europeans.. Arch. Neurol.. 2007; 64(3):425-30
ItalyNANA5 families/50 familiesNAGonzález-Fernández MC et al., 2007González-Fernández MC, Lezcano E, Ross OA, Gómez-Esteban JC, Gómez-Busto F, Velasco F, Alvarez-Alvarez M, Rodríguez-Martínez MB, Ciordia R, Zarranz JJ, Farrer MJ, Mata IF, de Pancorbo MM, . Lrrk2-associated parkinsonism is a major cause of disease in Northern Spain.. Parkinsonism Relat. Disord.. 2007; 13(8):509-15
ItalyNANA13 patients/629 patientsNAGoldwurm S et al., 2005Goldwurm S, Di Fonzo A, Simons EJ, Rohé CF, Zini M, Canesi M, Tesei S, Zecchinelli A, Antonini A, Mariani C, Meucci N, Sacilotto G, Sironi F, Salani G, Ferreira J, Chien HF, Fabrizio E, Vanacore N, Dalla Libera A, Stocchi F, Diroma C, Lamberti P, Sampaio C, Meco G, Barbosa E, Bertoli-Avella AM, Breedveld GJ, Oostra BA, Pezzoli G, Bonifati V, . The G6055A (G2019S) mutation in LRRK2 is frequent in both early and late onset Parkinson's disease and originates from a common ancestor.. J. Med. Genet.. 2005; 42(11):e65
TunisiaNANA42% (38 familes/91 familes) 2600 years ago (95% CI: 1950-3850)Warren L et al., 2008Warren L, Gibson R, Ishihara L, Elango R, Xue Z, Akkari A, Ragone L, Pahwa R, Jankovic J, Nance M, Freeman A, Watts RL, Hentati F, . A founding LRRK2 haplotype shared by Tunisian, US, European and Middle Eastern families with Parkinson's disease.. Parkinsonism Relat. Disord.. 2008; 14(1):77-80
TurkeyNANA1 patientNAPirkevi C et al., 2009Pirkevi C, Lesage S, Condroyer C, Tomiyama H, Hattori N, Ertan S, Brice A, Başak AN, . A LRRK2 G2019S mutation carrier from Turkey shares the Japanese haplotype.. Neurogenetics. 2009; 10(3):271-3

Parkinson disease 8 || c.4321C>T

Phenotype:    Parkinson disease 8
Dna Change:    c.4321C>T
Protein Change:    p.Arg1441Cys
Mutation Type:    Substitution
Mutation Effect:    Missense
Location:    exon 31
Transcript:    NM_198578.3

PopulationEthnic GroupRegionMutation FrquencyCoalescence TimeReference
ItalyNASouthern (Campania region)8 patients/192 patientsNACriscuolo C et al., 2011Criscuolo C, De Rosa A, Guacci A, Simons EJ, Breedveld GJ, Peluso S, Volpe G, Filla A, Oostra BA, Bonifati V, De Michele G, . The LRRK2 R1441C mutation is more frequent than G2019S in Parkinson's disease patients from southern Italy.. Mov. Disord.. 2011; 26(9):1733-6
ItalyNANA10 families/50 familiesNAGonzález-Fernández MC et al., 2007González-Fernández MC, Lezcano E, Ross OA, Gómez-Esteban JC, Gómez-Busto F, Velasco F, Alvarez-Alvarez M, Rodríguez-Martínez MB, Ciordia R, Zarranz JJ, Farrer MJ, Mata IF, de Pancorbo MM, . Lrrk2-associated parkinsonism is a major cause of disease in Northern Spain.. Parkinsonism Relat. Disord.. 2007; 13(8):509-15
SpainNAAsturias region2.7% (5 patiens/182 patiens)NAMata IF et al., 2005Mata IF, Taylor JP, Kachergus J, Hulihan M, Huerta C, Lahoz C, Blazquez M, Guisasola LM, Salvador C, Ribacoba R, Martinez C, Farrer M, Alvarez V, . LRRK2 R1441G in Spanish patients with Parkinson's disease.. Neurosci. Lett.. 2005; 382(3):309-11
SpainNANorthern (Basque population)NA1.350 years agoMata IF et al., 2009Mata IF, Hutter CM, González-Fernández MC, de Pancorbo MM, Lezcano E, Huerta C, Blazquez M, Ribacoba R, Guisasola LM, Salvador C, Gómez-Esteban JC, Zarranz JJ, Infante J, Jankovic J, Deng H, Edwards KL, Alvarez V, Zabetian CP, . Lrrk2 R1441G-related Parkinson's disease: evidence of a common founding event in the seventh century in Northern Spain.. Neurogenetics. 2009; 10(4):347-53

Parkinson disease 8 || c.4321C>G

Phenotype:    Parkinson disease 8
Dna Change:    c.4321C>G
Protein Change:    p.Arg1441Gly
Mutation Type:    Substitution
Mutation Effect:    Missense
Location:    exon 31
Transcript:    NM_198578.3

PopulationEthnic GroupRegionMutation FrquencyCoalescence TimeReference
SpainNABasques17 patients /276 patientsNASimón-Sánchez J et al., 2006Simón-Sánchez J, Martí-Massó JF, Sánchez-Mut JV, Paisán-Ruiz C, Martínez-Gil A, Ruiz-Martínez J, Sáenz A, Singleton AB, López de Munain A, Pérez-Tur J, . Parkinson\\\'s disease due to the R1441G mutation in Dardarin: a founder effect in the Basques.. Mov. Disord.. 2006; 21(11):1954-9

References

Criscuolo C, De Rosa A, Guacci A, Simons EJ, Breedveld GJ, Peluso S, Volpe G, Filla A, Oostra BA, Bonifati V, De Michele G, The LRRK2 R1441C mutation is more frequent than G2019S in Parkinson's disease patients from southern Italy.Mov. Disord.. 2011; 26(9):1733-6

Goldwurm S, Di Fonzo A, Simons EJ, Rohé CF, Zini M, Canesi M, Tesei S, Zecchinelli A, Antonini A, Mariani C, Meucci N, Sacilotto G, Sironi F, Salani G, Ferreira J, Chien HF, Fabrizio E, Vanacore N, Dalla Libera A, Stocchi F, Diroma C, Lamberti P, Sampaio C, Meco G, Barbosa E, Bertoli-Avella AM, Breedveld GJ, Oostra BA, Pezzoli G, Bonifati V, The G6055A (G2019S) mutation in LRRK2 is frequent in both early and late onset Parkinson's disease and originates from a common ancestor.J. Med. Genet.. 2005; 42(11):e65

González-Fernández MC, Lezcano E, Ross OA, Gómez-Esteban JC, Gómez-Busto F, Velasco F, Alvarez-Alvarez M, Rodríguez-Martínez MB, Ciordia R, Zarranz JJ, Farrer MJ, Mata IF, de Pancorbo MM, Lrrk2-associated parkinsonism is a major cause of disease in Northern Spain.Parkinsonism Relat. Disord.. 2007; 13(8):509-15

Lesage S, Janin S, Lohmann E, Leutenegger AL, Leclere L, Viallet F, Pollak P, Durif F, Thobois S, Layet V, Vidailhet M, Agid Y, Dürr A, Brice A, , Bonnet AM, Borg M, Broussolle E, Damier P, Destée A, Martinez M, Penet C, Rasco O, Tison F, Tranchan C, Vérin M, LRRK2 exon 41 mutations in sporadic Parkinson disease in Europeans.Arch. Neurol.. 2007; 64(3):425-30

Mata IF, Hutter CM, González-Fernández MC, de Pancorbo MM, Lezcano E, Huerta C, Blazquez M, Ribacoba R, Guisasola LM, Salvador C, Gómez-Esteban JC, Zarranz JJ, Infante J, Jankovic J, Deng H, Edwards KL, Alvarez V, Zabetian CP, Lrrk2 R1441G-related Parkinson's disease: evidence of a common founding event in the seventh century in Northern Spain.Neurogenetics. 2009; 10(4):347-53

Mata IF, Taylor JP, Kachergus J, Hulihan M, Huerta C, Lahoz C, Blazquez M, Guisasola LM, Salvador C, Ribacoba R, Martinez C, Farrer M, Alvarez V, LRRK2 R1441G in Spanish patients with Parkinson's disease.Neurosci. Lett.. 2005; 382(3):309-11

Pirkevi C, Lesage S, Condroyer C, Tomiyama H, Hattori N, Ertan S, Brice A, Başak AN, A LRRK2 G2019S mutation carrier from Turkey shares the Japanese haplotype.Neurogenetics. 2009; 10(3):271-3

Simón-Sánchez J, Martí-Massó JF, Sánchez-Mut JV, Paisán-Ruiz C, Martínez-Gil A, Ruiz-Martínez J, Sáenz A, Singleton AB, López de Munain A, Pérez-Tur J, Parkinson\\\'s disease due to the R1441G mutation in Dardarin: a founder effect in the Basques.Mov. Disord.. 2006; 21(11):1954-9

Warren L, Gibson R, Ishihara L, Elango R, Xue Z, Akkari A, Ragone L, Pahwa R, Jankovic J, Nance M, Freeman A, Watts RL, Hentati F, A founding LRRK2 haplotype shared by Tunisian, US, European and Middle Eastern families with Parkinson's disease.Parkinsonism Relat. Disord.. 2008; 14(1):77-80